0.2314
4.23%
0.0094
Viracta Therapeutics Inc (VIRX) 最新ニュース
Viracta Therapeutics' SWOT analysis: narrowed focus shapes stock outlook By Investing.com - Investing.com South Africa
Viracta Therapeutics' SWOT analysis: narrowed focus shapes stock outlook - Investing.com
Viracta Therapeutics' SWOT analysis: narrowed focus shapes stock outlook By Investing.com - Investing.com Canada
The Psychology of Viracta Therapeutics Inc Inc. (VIRX) Price Performance: Understanding Market Sentiment - The InvestChronicle
Viracta Therapeutics Inc (VIRX) Stock: Navigating a Year of Volatility - The InvestChronicle
Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Are Smart Investors Making the Right Decision? Viracta Therapeutics Inc (VIRX) - SETE News
Ratio Review: Analyzing Viracta Therapeutics Inc (VIRX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
What is the investor’s view on Viracta Therapeutics Inc (VIRX)? - US Post News
Viracta Therapeutics Inc (VIRX) can make a big difference with a little luck - SETE News
Viracta Therapeutics Inc (VIRX)’s stock decline to 0.22 per share - US Post News
Ratio Analysis: Unpacking Viracta Therapeutics Inc (VIRX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Viracta Therapeutics stock hits 52-week low at $0.27 - Investing.com
Here's Why Sunesis (VIRX) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
Here's Why Sunesis (VIRX) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Perhaps timely catching Viracta Therapeutics Inc (VIRX) would be a good idea - SETE News
Biopharma Layoff Tracker 2024: Lykos, Galera, Grail and More Cut Staff - BioSpace
Examining Viracta Therapeutics Inc (VIRX) stock is warranted - US Post News
Viracta Therapeutics Inc: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle
Stock Surge: Viracta Therapeutics Inc (VIRX) Closes at 0.31, Marking a -11.76 Increase/Decrease - The Dwinnex
Viracta Therapeutics (NASDAQ:VIRX) PT Lowered to $4.00 - Defense World
Viracta Therapeutics (NASDAQ:VIRX) Downgraded by SVB Leerink to “Market Perform” - Defense World
What is Viracta Therapeutics Inc (VIRX) Stock Return on Shareholders’ Capital? - SETE News
Viracta Therapeutics stock PT lowered by RBC amid pipeline strategy shift - Investing.com Canada
Viracta reports progress in PTCL treatment trial By Investing.com - Investing.com Australia
Sunesis: Q2 Earnings Snapshot - San Antonio Express-News
Sunesis: Q2 Earnings Snapshot - Thehour.com
Viracta reports progress in PTCL treatment trial - Investing.com
A Closer Look at Viracta Therapeutics Inc (VIRX) Stock Gains - The InvestChronicle
Sunesis: Q2 Earnings Snapshot - The Washington Post
VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024 - MSN
VIRX stock touches 52-week low at $0.38 amid market challenges - Investing.com Canada
New CEOs and positive earnings have these stocks moving - RagingBull
Sunesis: Q2 Earnings Snapshot - San Francisco Chronicle
Viracta Therapeutics Announces Positive Data from the Phase - GlobeNewswire
Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday? - Benzinga
Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today? - InvestorPlace
Viracta stock jumps after corporate update (NASDAQ:VIRX) - Seeking Alpha
VIRXViracta Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan
Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - StockTitan
Are Viracta Therapeutics Inc’shares a good deal? - US Post News
Daily Market Movement: Viracta Therapeutics Inc (VIRX) Sees a 0.59 Increase, Closing at 0.44 - The Dwinnex
VIRX stock touches 52-week low at $0.43 amid market challenges - Investing.com
Viracta Therapeutics announces workforce reduction - Investing.com
Short Interest in Viracta Therapeutics, Inc. (NASDAQ:VIRX) Grows By 35.2% - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap Up to $28.09 - Defense World
Viracta Therapeutics (NASDAQ:VIRX) Trading Down 1.1% - Defense World
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement - Quantisnow
Viracta Therapeutics (NASDAQ:VIRX) Stock Price Down 1.8% - Defense World
Can Viracta Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Viracta Therapeutics Announces New Employment Inducement Grant - Quantisnow
Viracta Therapeutics to Present at Upcoming May Investor Conferences - Quantisnow
Viracta Therapeutics to Present at the Jefferies Healthcare Conference - Quantisnow
Viracta Therapeutics Announces Orphan Drug Designation Granted by the European Commission for Nana-val for the ... - Quantisnow
Viracta Therapeutics Announces Departure of Chief Medical Officer - Quantisnow
Viracta Therapeutics to Present at the Stifel 2023 Targeted Oncology Days - Quantisnow
Viracta Therapeutics to Host Key Opinion Leader Webinar on Nana-val for the Treatment of Advanced Epstein-Barr ... - Quantisnow
Viracta Therapeutics President and Chief Executive Officer Dr. Ivor Royston Receives the Science History Institute's ... - Quantisnow
Viracta Therapeutics Announces Chief Executive Officer Leadership Succession to Drive the Next Phase of the ... - Quantisnow
XOMA receives $8.1 million from Viracta Therapeutics By Investing.com - Investing.com
XOMA receives $8.1 million from Viracta Therapeutics By Investing.com - Investing.com UK
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher - Yahoo Finance
Viracta Therapeutics (VIRX) Price Target Decreased by 5.41% to 14.28 - MSN
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace
Has IMARA (IMRA) Outpaced Other Medical Stocks This Year? - Yahoo Singapore News
大文字化:
|
ボリューム (24 時間):